Drug Type Biosimilar, Monoclonal antibody |
Synonyms Dupilumab Biosimilar (Neuracle Science Co., Ltd.), NS 402, NS-402 |
Target |
Mechanism IL-4Rα inhibitors(Interleukin-4 receptor subunit alpha inhibitors) |
Active Indication |
Inactive Indication- |
Originator Organization Neuracle Science Co., Ltd.Startup |
Active Organization Neuracle Science Co., Ltd.Startup |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Dermatitis, Atopic | Preclinical | KR | Neuracle Science Co., Ltd.Startup | - |